INNOCARE(09969) - 2025 Q4 - Earnings Call Transcript

InnoCare Pharma (SEHK:09969) Q4 2025 Earnings call March 25, 2026 08:30 AM ET Speaker8Great. Good morning and good evening our global investors. Thank you for joining InnoCare 2025 annual results earnings call. This is Ziyi Chen, China Healthcare Analyst at Goldman Sachs. Before we kick off the session, I would like to highlight that this call is strictly for clients of Goldman Sachs and InnoCare only, and this conversation is not intended for media and is off the record. Participants will be removed on the ...